ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 239,99
0,17%
Dow Jones
39 908,00
0,88%
DAX
18 869,36
0,78%
Brent Oil
82,705
0,19%
Bitcoin
66 111,43
7,42%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sonoma Pharmaceuticals Inc (SNOA)

  7. Sonoma Pharmaceuticals Inc (SNOA) Actualités

SNOA

Sonoma Pharmaceuticals (SNOA)

Sonoma Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SNOA
DateHeureSourceTitreSymboleSociété
08/03/202422h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNOASonoma Pharmaceuticals Inc
08/03/202422h27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNOASonoma Pharmaceuticals Inc
08/02/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNOASonoma Pharmaceuticals Inc
29/12/202323h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
21/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SNOASonoma Pharmaceuticals Inc
03/11/202321h30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SNOASonoma Pharmaceuticals Inc
30/10/202312h30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SNOASonoma Pharmaceuticals Inc
13/10/202323h19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SNOASonoma Pharmaceuticals Inc
11/10/202322h30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SNOASonoma Pharmaceuticals Inc
21/09/202315h35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:SNOASonoma Pharmaceuticals Inc
19/09/202322h30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SNOASonoma Pharmaceuticals Inc
27/07/202322h30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNOASonoma Pharmaceuticals Inc
21/07/202323h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SNOASonoma Pharmaceuticals Inc
21/06/202322h17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
10/05/202313h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
14/02/202322h35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNOASonoma Pharmaceuticals Inc
25/01/202315h25AllPennyStocks.comPremarket Is Shaping Up To Be Wild For This Micro CapNASDAQ:SNOASonoma Pharmaceuticals Inc
30/12/202223h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNOASonoma Pharmaceuticals Inc
23/12/202223h01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SNOASonoma Pharmaceuticals Inc
12/10/202223h04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNOASonoma Pharmaceuticals Inc
29/06/202222h03Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:SNOASonoma Pharmaceuticals Inc
01/06/202212h00Business WireSonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19NASDAQ:SNOASonoma Pharmaceuticals Inc
03/05/202212h00Business WireSonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.NASDAQ:SNOASonoma Pharmaceuticals Inc
30/03/202212h00Business WireSonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South AfricaNASDAQ:SNOASonoma Pharmaceuticals Inc
11/02/202222h30Business WireSonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial ResultsNASDAQ:SNOASonoma Pharmaceuticals Inc
20/01/202222h40Business WireSonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and ChinaNASDAQ:SNOASonoma Pharmaceuticals Inc
13/01/202222h02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNOASonoma Pharmaceuticals Inc
05/01/202222h55Business WireSonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022NASDAQ:SNOASonoma Pharmaceuticals Inc
15/11/202114h00Business WireSonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial ResultsNASDAQ:SNOASonoma Pharmaceuticals Inc
09/11/202113h00Business WireSonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast AsiaNASDAQ:SNOASonoma Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNOA

Dernières Valeurs Consultées

ASX
BOT
Botanix Pharmaceuticals
ASX
BML
Boab Metals
KUCN
CETUSUSDT
Cetus Protocol
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés